Thiazolo[4,5-C]pyridine derivatives
US7659401B2 · kind B2 · utility
2Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2006 |
| Grant date | Feb 9, 2010 |
| Priority date | — |
| Expiry date | Jul 24, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of general formula I:wherein R1, R2 and R3 are as defined in the description such compounds are metabotropic glutamate receptor antagonists and are useful in the treatment or prevention of mGluR5 receptor mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.